H1N1: vaccination progress in U.S. and abroad
The distribution of vaccines, which started more slowly than expected, is well below forecasts of the federal government, which has the effect of creating a large frustration in the population.
United States: a big frustration
The influenza A (H1N1) is widespread in 48 states. Center Control and Prevention (CDC) in Atlanta has revised upward the number of victims of this new form of flu with 4,000 deaths instead of 1,200.
41 million doses were available by November 10, three times less than what had been forecast in the spring. Only 33 million were sent to the States because of the red tape. The vaccine is not distributed accordingly to the evolution of the epidemic, but to the number of inhabitants.
Some less populous states but also affected are disadvantaged. In some states, we see long queues to get vaccinated. But frustration does not necessarily mean that a majority of Americans want to be vaccinated.
A survey by the Harvard School of Public Health indicates that only 17% of adults have tried so far to be vaccinated in the United States. Among them, 70% have failed. 41% of parents have tried to vaccinate their children, 66% in vain. According to a survey by Purdue University, 62% of Americans do not intend to be vaccinated in part because the vaccine will come too late, but also because they are not sure of its safety.
China: an early campaign
To prevent early epidemic, China has launched its vaccination campaign in late September. Voluntary and free, the vaccine was injected to eleven million people so far. More than 41 million doses have been distributed to hospitals across the country to start the campaign and around 100 million doses should be produced in the first quarter of 2010, according to calculations by authorities.
Beijing has recorded over 63,000 cases of influenza A and 36 people died of the virus since early October. The Chinese government plans to vaccinate nearly 380 million people. The vaccination campaign started rumors on the Internet. At that point the Ministry of Health had to publish a disclaimer, stating that some cases reported among students in early October had nothing to do with the vaccine.
United Kingdom: GPs to maneuver
The national campaign of vaccination against influenza A began two weeks ago in the United Kingdom, and millions of doses have finally arrived in the offices of general practitioners (GP).
The groups considered most at risk are men and women aged 6 months to 65 years, suffering from chronic respiratory diseases like asthma, heart problems or kidney problems and diabetes. The British government has already received enough to vaccinate 14 million people, with doses of Pandemrix.
Recommended articles:
An H1N1 vaccine as nasal spray in the U.S.
What is the Guillain-Barre syndrome?
Influenza A and pregnancy
Most recent in the category Social Health:
- Usage of Zithromax: A Powerful Antibiotic
- One bed - one habbit
- Be Beneficial by First Aid Training and Courses
- The Advantages of Electric Cigarette Refill
- Researchers managed prevent the aging process in mice
- GPS shoes for Alzheimer patients
- The "standing offices"
- A blood test to know the sex of your child
Last comments
Most read - Social Health
- Embryonic stem cells: first clinical trials
- The "standing offices"
- Contaminated vegetables: Origin of the deadly bacteria still unknown
- Copper to combat infections in hospital
- Proper use iodine tablets
- Alcohol can damage sperm
- Cohabitation reduces stress
- More strokes in winter?
- A blood test to know the sex of your child
- Communicating through the nasal breathing
Top rated - Social Health
- The worrisome antibiotic resistance
- Cohabitation reduces stress
- Communicating through the nasal breathing
- More strokes in winter?
- Alcohol can damage sperm
- Bisphenol A: new danger again?
- Embryonic stem cells: first clinical trials
- EU bans baby bottles containing bisphenol A
- Passive smoking kills over 600,000 people each year worldwide
- Thelin: Withdrawal from sale
No comments. Be the first to comment the article!